1115 related articles for article (PubMed ID: 32176691)
1. Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.
Hamrouni S; Bras-Gonçalves R; Kidar A; Aoun K; Chamakh-Ayari R; Petitdidier E; Messaoudi Y; Pagniez J; Lemesre JL; Meddeb-Garnaoui A
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008093. PubMed ID: 32176691
[TBL] [Abstract][Full Text] [Related]
2. In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response.
Seyed N; Zahedifard F; Safaiyan S; Gholami E; Doustdari F; Azadmanesh K; Mirzaei M; Saeedi Eslami N; Khadem Sadegh A; Eslami Far A; Sharifi I; Rafati S
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1295. PubMed ID: 21909442
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and Functional Profiles of Antigen-Specific CD4
Egui A; Ledesma D; Pérez-Antón E; Montoya A; Gómez I; Robledo SM; Infante JJ; Vélez ID; López MC; Thomas MC
Front Cell Infect Microbiol; 2018; 8():393. PubMed ID: 30510917
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analyses of immunogenic T-cell epitopes of LeIF and PpSP15 proteins from Leishmania major and sand fly saliva used as model antigens for the design of a multi-epitope vaccine to control leishmaniasis.
Bordbar A; Bagheri KP; Ebrahimi S; Parvizi P
Infect Genet Evol; 2020 Jun; 80():104189. PubMed ID: 31931259
[TBL] [Abstract][Full Text] [Related]
5. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
6. Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects.
Vijayamahantesh ; Amit A; Dikhit MR; Singh AK; Venkateshwaran T; Das VNR; Das P; Bimal S
Microbes Infect; 2017 Jun; 19(6):358-369. PubMed ID: 28373107
[TBL] [Abstract][Full Text] [Related]
7. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
Kashyap M; Jaiswal V; Farooq U
Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine.
Seyed N; Taheri T; Vauchy C; Dosset M; Godet Y; Eslamifar A; Sharifi I; Adotevi O; Borg C; Rohrlich PS; Rafati S
PLoS One; 2014; 9(10):e108848. PubMed ID: 25310094
[TBL] [Abstract][Full Text] [Related]
9. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH
Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of Potential CD4
E Silva RF; de Oliveira BC; da Silva AA; Brelaz de Castro MCA; Ferreira LFGR; Hernandes MZ; de Brito MEF; de-Melo-Neto OP; Rezende AM; Pereira VRA
Front Immunol; 2019; 10():3145. PubMed ID: 32117204
[No Abstract] [Full Text] [Related]
12. Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8
Rodrigues LS; Barreto AS; Bomfim LGS; Gomes MC; Ferreira NLC; da Cruz GS; Magalhães LS; de Jesus AR; Palatnik-de-Sousa CB; Corrêa CB; de Almeida RP
Front Immunol; 2021; 12():773983. PubMed ID: 34777391
[TBL] [Abstract][Full Text] [Related]
13. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS
Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582
[TBL] [Abstract][Full Text] [Related]
14. Identification of a First Human Norovirus CD8
Malm M; Vesikari T; Blazevic V
Front Immunol; 2018; 9():2782. PubMed ID: 30542352
[TBL] [Abstract][Full Text] [Related]
15. A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection.
Martins VT; Lage DP; Duarte MC; Carvalho AM; Costa LE; Mendes TA; Vale DL; Menezes-Souza D; Roatt BM; Tavares CA; Soto M; Coelho EA
Cell Immunol; 2017 Mar; 313():32-42. PubMed ID: 28049560
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with a CD4
Dias DS; Ribeiro PAF; Martins VT; Lage DP; Costa LE; Chávez-Fumagalli MA; Ramos FF; Santos TTO; Ludolf F; Oliveira JS; Mendes TAO; Silva ES; Galdino AS; Duarte MC; Roatt BM; Menezes-Souza D; Teixeira AL; Coelho EAF
Transl Res; 2018 Oct; 200():18-34. PubMed ID: 29908151
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
[TBL] [Abstract][Full Text] [Related]
18. CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis.
Nateghi Rostami M; Keshavarz H; Edalat R; Sarrafnejad A; Shahrestani T; Mahboudi F; Khamesipour A
PLoS Negl Trop Dis; 2010 Oct; 4(10):e845. PubMed ID: 20967288
[TBL] [Abstract][Full Text] [Related]
19. Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC).
Dikhit MR; Amit A; Singh AK; Kumar A; Mansuri R; Sinha S; Topno RK; Mishra R; Das VNR; Pandey K; Sahoo GC; Ali V; Bimal S; Das P
Parasite Immunol; 2017 Sep; 39(9):. PubMed ID: 28665520
[TBL] [Abstract][Full Text] [Related]
20. Leishmania major large RAB GTPase is highly immunogenic in individuals immune to cutaneous and visceral leishmaniasis.
Chamakh-Ayari R; Chenik M; Chakroun AS; Bahi-Jaber N; Aoun K; Meddeb-Garnaoui A
Parasit Vectors; 2017 Apr; 10(1):185. PubMed ID: 28416006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
